Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2026)
Top medical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Industry: Medical Instruments & Sup...

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Medical is Zen Rated B and is the 33rd ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
NEPH	NEPHROS INC	$4.43	-1.34%	-10.32%	-9.03%	-18.27%	23.06%	168.48%	235.61%	-46.69%	26.21%	$6.42	$1.39	31.00%	218.71%	0.61	15,300	-61.75%
INFU	INFUSYSTEM HOLDINGS INC	$8.48	-1.97%	0.95%	-5.36%	-15.28%	43.73%	2.54%	-13.20%	-51.54%	202.86%	$11.04	$4.61	23.19%	83.95%	0.90	150,000	-5.06%
NVST	ENVISTA HOLDINGS CORP	$24.11	0.25%	-0.94%	10.55%	18.48%	16.25%	11.62%	-37.12%	-31.89%	N/A	$25.41	$14.22	5.10%	69.55%	1.02	1,718,000	15.77%
KRMD	KORU MEDICAL SYSTEMS INC	$5.68	0.89%	1.79%	-6.27%	37.53%	66.57%	36.87%	45.27%	33.96%	1,220.93%	$6.61	$1.86	14.04%	205.38%	0.96	61,400	-5.54%
EMBC	EMBECTA CORP	$10.40	-3.17%	-15.38%	-12.31%	-26.08%	-8.21%	-46.39%	-62.04%	N/A	N/A	$19.00	$9.20	45.26%	13.04%	0.94	863,000	-16.54%
MMSI	MERIT MEDICAL SYSTEMS INC	$82.40	-0.17%	0.86%	-6.60%	-0.42%	-2.44%	-22.14%	17.82%	41.02%	412.44%	$111.45	$78.12	26.07%	5.48%	0.87	420,000	12.90%
BLCO	BAUSCH & LOMB CORP	$16.84	-0.18%	-1.46%	-1.81%	9.56%	16.62%	-3.50%	-2.09%	N/A	N/A	$18.14	$10.45	7.17%	61.15%	1.08	255,000	79.58%
ATRC	ATRICURE INC	$38.41	-0.26%	-0.03%	-4.98%	5.32%	15.62%	-5.95%	-11.29%	-33.20%	113.98%	$43.18	$28.29	11.05%	35.77%	1.21	472,000	6.79%
HBIO	HARVARD BIOSCIENCE INC	$0.59	2.78%	1.55%	-10.73%	47.01%	11.72%	-67.17%	-80.03%	-86.98%	-78.03%	$1.83	$0.28	67.70%	110.32%	1.40	246,000	11.82%
AZTA	AZENTA INC	$40.13	0.70%	1.54%	15.72%	25.88%	17.58%	-26.35%	-29.47%	-46.68%	335.25%	$55.64	$23.91	27.87%	67.84%	1.56	317,000	-47.52%
ISRG	INTUITIVE SURGICAL INC	$525.04	-0.71%	-0.46%	-8.75%	-4.75%	6.29%	-8.45%	112.34%	107.60%	784.86%	$609.08	$425.00	13.80%	23.54%	1.29	1,504,000	-41.36%
HAE	HAEMONETICS CORP	$67.87	-0.73%	-3.18%	-15.72%	32.53%	-9.09%	-4.80%	-20.32%	-40.49%	119.01%	$87.32	$47.32	22.27%	43.43%	0.80	732,000	-1.35%
WST	WEST PHARMACEUTICAL SERVICES INC	$240.53	-0.36%	-3.98%	-12.72%	-16.26%	-6.68%	-30.30%	-10.46%	-17.97%	323.39%	$347.85	$187.43	30.85%	28.33%	0.91	935,000	16.73%
STVN	STEVANATO GROUP SPA	$16.97	-1.79%	-11.15%	-17.82%	-34.68%	-34.66%	-19.73%	-16.49%	N/A	N/A	$28.00	$16.30	39.39%	4.11%	0.91	1,028,000	4.58%
ICUI	ICU MEDICAL INC	$149.27	-2.35%	-2.58%	1.39%	21.45%	17.07%	-13.36%	-22.45%	-26.60%	54.40%	$173.85	$107.00	14.14%	39.50%	0.98	221,000	-17.23%
BAX	BAXTER INTERNATIONAL INC	$19.57	-0.41%	0.98%	1.66%	-15.54%	-31.38%	-41.51%	-57.46%	-74.92%	-46.38%	$37.74	$17.40	48.15%	12.47%	0.63	5,869,000	29.85%
RGEN	REPLIGEN CORP	$163.63	0.18%	0.18%	-1.27%	1.57%	36.76%	-2.61%	-16.15%	-12.65%	636.08%	$177.17	$102.97	7.64%	58.92%	1.44	455,000	-8.45%
BLFS	BIOLIFE SOLUTIONS INC	$24.98	0.16%	0.89%	-0.56%	-10.91%	12.37%	-11.67%	6.30%	-32.61%	1,250.27%	$29.62	$19.10	15.67%	30.79%	1.86	180,000	-16.28%
BDX	BECTON DICKINSON & CO	$203.40	-0.01%	0.00%	4.22%	8.75%	11.18%	-18.21%	-19.23%	-18.93%	39.28%	$251.99	$162.29	19.28%	25.33%	0.47	1,885,000	93.93%
LMAT	LEMAITRE VASCULAR INC	$85.33	0.06%	-0.55%	2.86%	-5.32%	3.47%	-13.86%	85.99%	75.07%	484.85%	$105.55	$71.42	19.16%	19.48%	0.80	101,000	38.36%
ANGO	ANGIODYNAMICS INC	$10.24	-0.87%	-1.16%	-20.44%	-16.68%	12.28%	-16.20%	-21.17%	-46.16%	-5.80%	$13.99	$8.27	26.80%	23.82%	1.01	405,000	-19.96%
RMD	RESMED INC	$255.50	0.01%	0.91%	5.21%	-1.43%	-6.58%	0.31%	13.76%	19.36%	343.81%	$293.81	$199.92	13.04%	27.80%	0.82	1,092,000	33.33%
ALC	ALCON INC	$80.87	0.10%	2.29%	0.65%	6.27%	-10.29%	-11.47%	8.11%	9.27%	N/A	$99.20	$71.55	18.48%	13.03%	0.82	976,000	78.10%
PDEX	PRO DEX INC	$41.23	0.88%	-1.20%	4.54%	42.81%	-22.93%	-0.10%	144.11%	27.37%	1,667.25%	$70.26	$23.47	41.32%	75.67%	0.56	30,000	41.51%
COO	COOPER COMPANIES INC	$80.70	-0.25%	0.11%	-1.82%	10.78%	10.68%	-18.85%	-6.29%	-10.51%	151.01%	$99.54	$61.78	18.92%	30.64%	0.89	1,461,000	9.68%
UTMD	UTAH MEDICAL PRODUCTS INC	$62.87	0.63%	2.52%	10.00%	6.14%	8.82%	-2.03%	-29.62%	-24.94%	13.07%	$64.46	$51.26	2.47%	22.64%	0.56	17,600	-51.78%
TFX	TELEFLEX INC	$104.52	0.31%	4.17%	-14.86%	-21.15%	-9.55%	-43.09%	-57.14%	-71.92%	-22.53%	$184.58	$100.18	43.37%	4.33%	0.86	1,449,000	95.28%
XRAY	DENTSPLY SIRONA INC	$12.77	0.39%	5.98%	13.51%	-2.44%	-20.54%	-34.88%	-65.49%	-76.94%	-78.29%	$20.60	$9.85	37.99%	29.64%	0.91	3,079,000	0.98%
ATR	APTARGROUP INC	$124.74	-1.27%	0.74%	1.24%	-3.14%	-21.40%	-21.28%	10.65%	-6.39%	77.57%	$164.28	$103.23	24.07%	20.84%	0.68	246,000	-7.87%
WRBY	WARBY PARKER INC	$27.29	-0.33%	1.87%	18.65%	26.93%	13.33%	6.68%	63.12%	N/A	N/A	$30.90	$13.63	11.68%	100.22%	1.91	2,411,000	3.57%
NNNN	ANBIO BIOTECHNOLOGY	$21.51	-5.12%	-30.19%	-33.59%	-10.08%	-57.68%	N/A	N/A	N/A	N/A	$55.65	$5.18	61.35%	315.25%	0.27	62,000	-27.06%
SMTI	SANARA MEDTECH INC	$20.80	-2.12%	-4.46%	-14.23%	-31.80%	-16.90%	-43.31%	-49.45%	-49.21%	246.67%	$37.91	$18.90	45.14%	10.05%	1.22	54,000	-21.05%
MDLN	MEDLINE INC	$46.31	3.28%	4.89%	10.26%	N/A	N/A	N/A	N/A	N/A	N/A	$46.66	$34.92	0.75%	32.62%	0.13	4,829,000	162.73%
EKSO	EKSO BIONICS HOLDINGS INC	$8.26	4.29%	0.49%	51.28%	67.89%	82.34%	-12.17%	-68.71%	-93.72%	-99.42%	$12.70	$2.73	34.96%	202.56%	0.83	149,000	-57.55%
LUCY	INNOVATIVE EYEWEAR INC	$1.30	-2.99%	2.36%	17.12%	-27.78%	-38.10%	-78.11%	-95.45%	N/A	N/A	$5.68	$0.95	77.11%	36.84%	1.00	223,000	18.62%
BNGO	BIONANO GENOMICS INC	$1.54	0.65%	6.94%	3.36%	-19.37%	-52.91%	-73.54%	-99.86%	-99.98%	N/A	$6.32	$1.42	75.61%	8.83%	2.07	204,000	85.45%
FEMY	FEMASYS INC	$0.60	-0.83%	-12.37%	-1.65%	-16.08%	-31.21%	-45.41%	-51.70%	N/A	N/A	$1.80	$0.31	66.94%	93.81%	0.55	676,000	40.54%
PLSE	PULSE BIOSCIENCES INC	$14.32	0.00%	3.54%	1.20%	-18.17%	-5.85%	-23.26%	346.11%	-58.42%	N/A	$25.00	$12.56	42.72%	14.01%	1.38	101,000	-40.24%
STXS	STEREOTAXIS INC	$2.53	-2.32%	-4.17%	10.00%	-17.05%	-2.32%	9.52%	11.45%	-42.89%	261.43%	$3.59	$1.54	29.53%	64.29%	1.16	340,000	23.64%
STSS	SHARPS TECHNOLOGY INC	$2.30	7.98%	5.50%	16.75%	-57.49%	-61.86%	-99.47%	-99.97%	N/A	N/A	$211.20	$1.65	98.91%	39.39%	0.64	591,000	-45.78%
KMTS	KESTRA MEDICAL TECHNOLOGIES LTD	$25.86	4.19%	12.43%	-2.16%	-4.47%	56.73%	N/A	N/A	N/A	N/A	$30.00	$13.25	13.80%	95.17%	1.17	242,000	63.51%
OSUR	ORASURE TECHNOLOGIES INC	$2.73	0.74%	5.41%	12.35%	-5.54%	-18.51%	-33.58%	-48.39%	-80.35%	-50.09%	$4.22	$2.08	35.31%	31.25%	1.07	436,000	7.13%
MBOT	MICROBOT MEDICAL INC	$1.97	2.60%	-5.29%	-6.64%	-17.57%	-32.07%	-1.50%	-38.24%	-78.89%	-99.65%	$4.67	$1.25	57.82%	57.60%	1.32	1,279,000	-6.78%
AVR	ANTERIS TECHNOLOGIES GLOBAL CORP	$6.31	0.32%	9.74%	20.19%	20.65%	88.36%	5.17%	N/A	N/A	N/A	$8.79	$2.34	28.21%	169.66%	1.74	725,000	-20.33%
AGPU	AXE COMPUTE INC	$5.04	2.86%	-15.86%	-31.24%	-45.81%	-58.00%	-75.83%	-96.31%	-98.56%	-100.00%	$39.00	$3.88	87.08%	29.90%	1.31	31,800	-69.71%
GCTK	GLUCOTRACK INC	$3.41	1.19%	-10.26%	-11.89%	-48.64%	-50.22%	-96.89%	-99.96%	-99.31%	-99.94%	$133.80	$3.21	97.45%	6.23%	4.37	75,000	139.62%
NXGL	NEXGEL INC	$1.58	-1.25%	2.60%	6.76%	-38.76%	-30.70%	-51.53%	16.18%	N/A	N/A	$4.00	$1.45	60.50%	8.97%	0.82	10,100	-83.05%
RGNT	REGENTIS BIOMATERIALS LTD	$6.68	0.45%	-5.92%	-5.52%	N/A	N/A	N/A	N/A	N/A	N/A	$8.35	$5.75	20.00%	16.17%	0.03	10,500	-45.03%
NYXH	NYXOAH SA	$4.76	-0.63%	0.63%	0.21%	-10.02%	-33.61%	-56.05%	-10.19%	N/A	N/A	$11.87	$4.35	59.90%	9.55%	0.43	46,000	-50.00%
RVP	RETRACTABLE TECHNOLOGIES INC	$0.72	-1.37%	-0.28%	-11.11%	-22.08%	-0.55%	-8.98%	-63.27%	-95.45%	-74.29%	$1.14	$0.62	36.84%	16.13%	0.85	67,000	-37.96%
STAA	STAAR SURGICAL CO	$19.04	-0.37%	-9.20%	-18.56%	-31.46%	-1.09%	-22.57%	-73.52%	-81.67%	191.13%	$30.81	$13.50	38.20%	41.04%	1.44	917,000	-30.42%
POCI	PRECISION OPTICS CORPORATION INC	$5.18	0.97%	17.19%	22.46%	22.75%	10.21%	3.60%	-15.36%	5.93%	245.33%	$5.34	$3.77	2.98%	37.55%	0.21	54,000	694.12%
ZTEK	ZENTEK LTD	$0.77	-1.79%	-7.03%	12.79%	-12.84%	-20.85%	-32.72%	-48.87%	N/A	N/A	$1.84	$0.62	58.34%	23.71%	0.70	64,400	-8.00%
HOLX	HOLOGIC INC	$75.20	0.01%	0.12%	0.93%	1.69%	14.48%	3.37%	-9.17%	3.71%	110.23%	$75.36	$51.90	0.21%	44.89%	0.51	4,476,000	359.08%
ZJYL	JIN MEDICAL INTERNATIONAL LTD	$0.15	7.09%	14.39%	-32.29%	-51.60%	-77.16%	-80.89%	N/A	N/A	N/A	$1.03	$0.12	85.27%	31.30%	1.10	3,206,000	66.89%
CUPR	CUPRINA HOLDINGS (CAYMAN) LTD	$0.47	8.06%	0.00%	9.07%	-51.55%	-93.97%	N/A	N/A	N/A	N/A	$9.50	$0.38	95.06%	24.73%	0.67	317,000	217.00%
MLSS	MILESTONE SCIENTIFIC INC	$0.30	0.67%	6.03%	3.10%	-35.00%	-38.60%	-77.52%	-60.40%	-89.55%	-83.57%	$1.35	$0.22	77.85%	37.16%	1.14	27,100	-80.78%

Medical Stocks FAQ

What are the best medical stocks to buy right now in Jan 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best medical stocks to buy right now are:

1. Nephros (NASDAQ:NEPH)

Nephros (NASDAQ:NEPH) is the #1 top medical stock out of 57 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Nephros (NASDAQ:NEPH) is: Value: C, Growth: C, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Nephros (NASDAQ:NEPH) has a Due Diligence Score of 53, which is 23 points higher than the medical industry average of 30.

NEPH passed 17 out of 33 due diligence checks and has strong fundamentals. Nephros has seen its stock return 168.48% over the past year, overperforming other medical stocks by 197 percentage points.

Nephros has an average 1 year price target of $6.00, an upside of 35.44% from Nephros's current stock price of $4.43.

Nephros stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Nephros, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Infusystem Holdings (NYSEMKT:INFU)

Infusystem Holdings (NYSEMKT:INFU) is the #2 top medical stock out of 57 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Infusystem Holdings (NYSEMKT:INFU) is: Value: C, Growth: C, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Infusystem Holdings (NYSEMKT:INFU) has a Due Diligence Score of 45, which is 15 points higher than the medical industry average of 30.

INFU passed 14 out of 33 due diligence checks and has strong fundamentals. Infusystem Holdings has seen its stock return 2.54% over the past year, overperforming other medical stocks by 31 percentage points.

Infusystem Holdings has an average 1 year price target of $14.50, an upside of 70.99% from Infusystem Holdings's current stock price of $8.48.

Infusystem Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Infusystem Holdings, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Envista Holdings (NYSE:NVST)

Envista Holdings (NYSE:NVST) is the #3 top medical stock out of 57 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Envista Holdings (NYSE:NVST) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: A, Financials: C, and AI: C.

Envista Holdings (NYSE:NVST) has a Due Diligence Score of 36, which is 6 points higher than the medical industry average of 30.

NVST passed 11 out of 33 due diligence checks and has average fundamentals. Envista Holdings has seen its stock return 11.62% over the past year, overperforming other medical stocks by 40 percentage points.

Envista Holdings has an average 1 year price target of $21.50, a downside of -10.83% from Envista Holdings's current stock price of $24.11.

Envista Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Envista Holdings, 25% have issued a Strong Buy rating, 0% have issued a Buy, 75% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the medical stocks with highest dividends?

Out of 10 medical stocks that have issued dividends in the past year, the 3 medical stocks with the highest dividend yields are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) has an annual dividend yield of 5.77%, which is 4 percentage points higher than the medical industry average of 2.18%.

Embecta's dividend payout ratio of 36.6% indicates that its high dividend yield is sustainable for the long-term.

2. Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) has an annual dividend yield of 5.01%, which is 3 percentage points higher than the medical industry average of 2.18%. Dentsply Sirona's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dentsply Sirona's dividend has shown consistent growth over the last 10 years.

Dentsply Sirona's dividend payout ratio of -14.6% indicates that its high dividend yield might not be sustainable for the long-term.

3. Baxter International (NYSE:BAX)

Baxter International (NYSE:BAX) has an annual dividend yield of 2.66%, which is the same as the medical industry average of 2.18%. Baxter International's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Baxter International's dividend has not shown consistent growth over the last 10 years.

Baxter International's dividend payout ratio of -103% indicates that its dividend yield might not be sustainable for the long-term.

Why are medical stocks down?

Medical stocks were down -0.3% in the last day, and down -0.61% over the last week.

We couldn't find a catalyst for why medical stocks are down.

What are the most undervalued medical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued medical stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued medical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 66 points higher than the medical industry average of 20. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -46.39% in the past year. It has underperformed other stocks in the medical industry by -18 percentage points.

2. Haemonetics (NYSE:HAE)

Haemonetics (NYSE:HAE) is the second most undervalued medical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Haemonetics has a valuation score of 43, which is 23 points higher than the medical industry average of 20. It passed 3 out of 7 valuation due diligence checks.

Haemonetics's stock has dropped -4.8% in the past year. It has overperformed other stocks in the medical industry by 23 percentage points.

3. Harvard Bioscience (NASDAQ:HBIO)

Harvard Bioscience (NASDAQ:HBIO) is the third most undervalued medical stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harvard Bioscience has a valuation score of 14, which is -6 points higher than the medical industry average of 20. It passed 1 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates HBIO a Valuation Rating of "B".

Harvard Bioscience's stock has dropped -67.17% in the past year. It has underperformed other stocks in the medical industry by -39 percentage points.

Are medical stocks a good buy now?

43.9% of medical stocks rated by analysts are a strong buy right now. On average, analysts expect medical stocks to rise by 20.68% over the next year.

13.33% of medical stocks have a Zen Rating of A (Strong Buy), 24.44% of medical stocks are rated B (Buy), 42.22% are rated C (Hold), 13.33% are rated D (Sell), and 6.67% are rated F (Strong Sell).

What is the average p/e ratio of the medical instruments & supplies industry?

The average P/E ratio of the medical instruments & supplies industry is 229.32x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2026)
Top medical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Medical Stocks FAQ

1. Nephros (NASDAQ:NEPH)

2. Infusystem Holdings (NYSEMKT:INFU)

3. Envista Holdings (NYSE:NVST)

1. Embecta (NASDAQ:EMBC)

2. Dentsply Sirona (NASDAQ:XRAY)

3. Baxter International (NYSE:BAX)

1. Embecta (NASDAQ:EMBC)

2. Haemonetics (NYSE:HAE)

3. Harvard Bioscience (NASDAQ:HBIO)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareMedical Instruments & SuppliesBest Medical Stocks to Buy Now (2026)Top medical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.

Medical Stocks FAQ

1. Nephros (NASDAQ:NEPH)

2. Infusystem Holdings (NYSEMKT:INFU)

3. Envista Holdings (NYSE:NVST)

1. Embecta (NASDAQ:EMBC)

2. Dentsply Sirona (NASDAQ:XRAY)

3. Baxter International (NYSE:BAX)

1. Embecta (NASDAQ:EMBC)

2. Haemonetics (NYSE:HAE)

3. Harvard Bioscience (NASDAQ:HBIO)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareMedical Instruments & Supplies
Best Medical Stocks to Buy Now (2026)
Top medical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best medical stocks to buy now. Learn More.